Ignite Creation Date:
2025-12-24 @ 10:35 PM
Ignite Modification Date:
2026-05-02 @ 2:13 AM
Study NCT ID:
NCT02398435
Status:
COMPLETED
Last Update Posted:
2016-12-06
First Post:
2015-02-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Therapeutic Use of Tadekinig Alfa in Adult-onset Still's Disease
Sponsor:
AB2 Bio Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Still's Disease, Adult-Onset | View |